Literature DB >> 26187790

Executive Dysfunction in Patients with Putaminal Hemorrhage.

Kae Kokubo1, Kyoko Suzuki2, Noriaki Hattori3, Ichiro Miyai3, Etsuro Mori4.   

Abstract

BACKGROUND: The frontal-subcortical circuits link the specific areas of the frontal cortex to the striatum, basal ganglia, and thalamus. Disruption of the frontal-subcortical circuits may lead to cognitive impairment with frontal lobe features. The putamen is a central component of frontal-subcortical circuits. Although putaminal lesions presumably lead to cognitive and behavioral changes, studies on frontal lobe dysfunctions after putaminal stroke are scarce. There are no previous studies that systematically examined frontal lobe functions with a focal putaminal lesion. The objective of this study is to demonstrate whether putaminal hemorrhage causes frontal lobe dysfunction.
METHODS: Cognitive functions, including various aspects of frontal lobe functions, were systematically assessed in 15 patients with left- or right-sided putaminal hemorrhage 2 months after the onset and compared with healthy controls.
RESULTS: Patients did not have signs of aphasia, apraxia, or spatial neglect. They performed significantly worse on tests of frontal lobe function, including Letter-Number Sequencing (U = 22, P < .001), lexical fluency (U = 30, P < .001), and motor series subtest (U = 45, P = .004) of the Frontal Assessment Battery. On the Wisconsin Card Sorting Test, patients performed significantly worse for "categories achieved" (U = 29.5, P < .001), "perseverative errors" (U = 25, P < .001), and "set loss" (U = 49, P = .008). None showed behavioral impairment.
CONCLUSIONS: Isolated putaminal hemorrhage causes modest frontal lobe dysfunction without behavioral symptoms. Our findings indicate that isolated putaminal hemorrhage disrupts the dorsolateral-striato-pallido-thalamic circuits and causes executive dysfunction.
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Putaminal hemorrhage; Wisconsin Card Sorting Test; executive dysfunction; the frontal–subcortical circuits; working memory

Mesh:

Year:  2015        PMID: 26187790     DOI: 10.1016/j.jstrokecerebrovasdis.2015.04.047

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping.

Authors:  Jing Li; Qihao Zhang; Nan Zhang; Lingfei Guo
Journal:  J Diabetes Res       Date:  2020-09-25       Impact factor: 4.011

2.  Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker.

Authors:  Yawen Sun; Xin Ge; Xu Han; Wenwei Cao; Yao Wang; Weina Ding; Mengqiu Cao; Yong Zhang; Qun Xu; Yan Zhou; Jianrong Xu
Journal:  Front Aging Neurosci       Date:  2017-03-30       Impact factor: 5.750

3.  Value of the Frontal Assessment Battery Tool for Assessing the Frontal Lobe Function in Stroke Patients.

Authors:  Mihyang Han; Da-Ye Kim; Ja-Ho Leigh; Min-Wook Kim
Journal:  Ann Rehabil Med       Date:  2020-07-28

4.  Post-Stroke Working Memory Dysfunction: A Meta-Analysis and Systematic Review.

Authors:  Selma Lugtmeijer; Nikki A Lammers; Edward H F de Haan; Frank-Erik de Leeuw; Roy P C Kessels
Journal:  Neuropsychol Rev       Date:  2020-11-24       Impact factor: 7.444

5.  Altered Spontaneous Brain Activity Related to Neurologic Dysfunction in Patients With Cerebral Small Vessel Disease.

Authors:  Mengmeng Feng; Hongwei Wen; Haotian Xin; Nan Zhang; Changhu Liang; Lingfei Guo
Journal:  Front Aging Neurosci       Date:  2021-12-17       Impact factor: 5.750

6.  Secondary injury to distal regions after intracerebral hemorrhage influence neurological functional outcome.

Authors:  Kangping Song; Xiaojie Liu; Qiuyue Zheng; Lingling Zhang; Hongying Zhang; Hailong Yu; Yan Zhu; Li-An Huang; Yingzhu Chen
Journal:  Aging (Albany NY)       Date:  2020-03-08       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.